Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) approved ADZYNMA®▼ (recombinant ADAMTS13) for the treatment of ADAMTS13 deficiency in children and adult patients...
GSK plc (LSE/NYSE: GSK) today announced that the European Commission has authorised Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) for active immunisation for the prevention of...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the discontinuation of the vibostolimab and pembrolizumab coformulation arm...
Neuralink, Elon Musk's brain-computer interface startup, has made significant strides in vision restoration technology. Their Blindsight device, recently granted FDA breakthrough device designation, aims...
Theratechnologies, a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced a risk of a temporary supply disruption for EGRIFTA SV® (tesamorelin...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global maternal health...
AbbVie breaks ground on a new central research building, “LUnA” (LUdwighafens neue Arbeitswelt) and is investing approximately €150 M in its second largest R&D...
Daiichi Sankyo (TSE: 4568) said today that it has chosen for Daiichi Sankyo RD Novare closure (based in Edogawa-ku, Tokyo; hereinafter referred to as...
Today on 18-July-2023, Flagship Pioneering, Inc. and Pfizer Inc. (NYSE: PFE) announced their collaboration to develop a fresh pipeline of cutting-edge pharmaceuticals. By utilising...
Recent Comments